Deal Snapshot
American Regent to Acquire Generic Drug Maker HBT Labs
Thursday 18 August 2022

US-based injectable pharmaceuticals manufacturer American Regent, Inc., with manufacturing sites in New York and Ohio, has acquired California-based HBT Labs, Inc, the company said.

HBT Labs has a pipeline of generic and 505(b) (2) pharmaceutical products that target various treatment indications including cancer and Central Nervous System disorders.

Date Published: 18/08/2022